CLARAVIS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Claravis, and when can generic versions of Claravis launch?
Claravis is a drug marketed by Teva Pharms Usa and is included in two NDAs.
The generic ingredient in CLARAVIS is isotretinoin. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the isotretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Claravis
A generic version of CLARAVIS was approved as isotretinoin by AMNEAL PHARMS NY on September 29th, 2017.
Summary for CLARAVIS
Recent Clinical Trials for CLARAVIS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| Children's Oncology Group | N/A |
| National Cancer Institute (NCI) | N/A |
Pharmacology for CLARAVIS
| Drug Class | Retinoid |
Anatomical Therapeutic Chemical (ATC) Classes for CLARAVIS
US Patents and Regulatory Information for CLARAVIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076356-001 | Apr 11, 2003 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076135-001 | Apr 11, 2003 | AB1 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076135-002 | Apr 11, 2003 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Teva Pharms Usa | CLARAVIS | isotretinoin | CAPSULE;ORAL | 076135-003 | May 11, 2006 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
